S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
These are the Top 4 Stocks for Buybacks in 2024
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
These are the Top 4 Stocks for Buybacks in 2024
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
These are the Top 4 Stocks for Buybacks in 2024
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
These are the Top 4 Stocks for Buybacks in 2024
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China

Knight Therapeutics (GUD) Insider Trading & Ownership

C$5.79
-0.07 (-1.19%)
(As of 04/18/2024 ET)

Knight Therapeutics (TSE:GUD) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
46.45%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
C$2.00 M
Number Of
Insiders Selling
(Last 12 Months)
1
Amount Of
Insider Selling
(Last 12 Months)
C$750,255.00
Get GUD Insider Trade Alerts

Want to know when executives and insiders are buying or selling Knight Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

GUD Insider Buying and Selling by Quarter

Knight Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
4/11/2024Sime ArmoyanInsiderSell10,900C$5.95C$64,855.00
4/1/2024Sime ArmoyanInsiderBuy6,200C$5.25C$32,550.00
3/25/2024Sime ArmoyanInsiderBuy351,000C$5.25C$1,842,750.00
1/22/2024Sime ArmoyanInsiderSell28,200C$5.75C$162,150.00
1/19/2024Sime ArmoyanInsiderSell91,000C$5.75C$523,250.00
10/23/2023Sime ArmoyanInsiderBuy1,100C$4.35C$4,785.00
9/15/2023Sime ArmoyanInsiderBuy26,400C$4.38C$115,737.60
(Data available from 1/1/2013 forward)

GUD Insider Trading Activity - Frequently Asked Questions

Who is on Knight Therapeutics's Insider Roster?

The list of insiders at Knight Therapeutics includes Arvind Utchanah, Janice Jean Murray, Jonathan Ross Goodman, Long Zone Holdings Inc. , Robert Nathaniel Lande, Samira Sakhia, and Sime Armoyan. Learn more on insiders at GUD.

What percentage of Knight Therapeutics stock is owned by insiders?

46.45% of Knight Therapeutics stock is owned by insiders. Learn more on GUD's insider holdings.

Which Knight Therapeutics insiders have been buying company stock?

The following insiders have purchased GUD shares in the last 24 months: Long Zone Holdings Inc. (C$196,640.00), Samira Sakhia (C$199,998.60), and Sime Armoyan (C$1,995,822.60).

How much insider buying is happening at Knight Therapeutics?

Insiders have purchased a total of 461,460 GUD shares in the last 24 months for a total of C$2,392,461.20 bought.

Which Knight Therapeutics insiders have been selling company stock?

The following insider sold GUD shares in the last 24 months: Sime Armoyan (C$1,710,468.05).

How much insider selling is happening at Knight Therapeutics?

Insiders have sold a total of 295,600 Knight Therapeutics shares in the last 24 months for a total of C$1,710,468.05 sold.


More Insider Trading Tools from MarketBeat

This page (TSE:GUD) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners